Assignee
MACREGEN INC
US·2 granted patents·4 pending applications·8 citations·filing 2017–2020
Top patents by PatentIndex Score
6 records- 0183US10426817B2Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimeticsMACREGEN INC·Filed 2017·Granted Oct 1, 2019·5 cites·24 claims
- 0277US10905770B2Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseasesMACREGEN INC·Filed 2018·Granted Feb 2, 2021·3 cites·19 claims
- 0357US2021138034A1Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimeticsMACREGEN INC·Filed 2020·Application pending·0 cites
- 0455US2020069770A1Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimeticsMACREGEN INC·Filed 2019·Application pending·0 cites
- 0549US2021085797A1Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseasesMACREGEN INC·Filed 2020·Application pending·0 cites
- 0638US2018296525A1Treatment of age-related macular degeneration and other eye diseases with one or more therapeutic agentsMACREGEN INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →